Waqas Khan1, Abdul Qayyum Rana. 1. Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, FitzGerald Building, 150 College Street, Toronto, ON, M5S-3E2, Canada.
Abstract
CASE DESCRIPTION: A patient diagnosed with type 2 diabetes mellitus and Parkinson's disease developed a compulsive eating disorder when treated with a dopamine agonist, pramipexole. The patient had no history of psychiatric illnesses and upon the discontinuation of pramipexole his abnormal behavioural symptoms were resolved. CONCLUSION: Physicians treating Parkinson's disease patients with dopamine replacement therapy should inquire about the development of any compulsive behaviours. Although uncommon, many of these non-motor symptoms go undiagnosed and can have a detrimental impact on a patient's quality of life.
CASE DESCRIPTION: A patient diagnosed with type 2 diabetes mellitus and Parkinson's disease developed a compulsive eating disorder when treated with a dopamine agonist, pramipexole. The patient had no history of psychiatric illnesses and upon the discontinuation of pramipexole his abnormal behavioural symptoms were resolved. CONCLUSION: Physicians treating Parkinson's diseasepatients with dopamine replacement therapy should inquire about the development of any compulsive behaviours. Although uncommon, many of these non-motor symptoms go undiagnosed and can have a detrimental impact on a patient's quality of life.
Authors: Ingrid de Chazeron; F Durif; C Lambert; I Chereau-Boudet; M L Fantini; A Marques; P Derost; B Debilly; G Brousse; Y Boirie; P M Llorca Journal: Sci Rep Date: 2021-05-25 Impact factor: 4.379